Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.

Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.

Item
http://www.wikidata.org/entity/Q38786058
Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular diseaseYirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice.Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition.The quest for immunotherapy in atherosclerosis: CANTOS study, interleukin-1β and vascular inflammation.Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?Antibiotics for secondary prevention of coronary heart disease
P2860

Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.

Item
http://www.wikidata.org/entity/Q38786058
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
@en
type
label
Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
@en
prefLabel
Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
@en
P2093
P2860
P304
P31
P356
10.1080/14728214.2017.1269743
P407
P433
P478
P577
P698
P921